LexDanaLexDanabeta
Inventor

Songyuan Shi

Inventor
Fremont, CA, US

Overview

28→
Patents
2002–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes26%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07CAcyclic or carbocyclic compounds3%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,899,761Heterocyclic compounds and uses thereof202110,703,757Compounds and methods for CDK8 modulation and indications therefor202010,647,716Heterocyclic compounds and uses thereof202010,519,177Heterocyclic compounds and uses thereof201910,426,760Compounds and methods for kinase modulation, and indications therefor201910,421,761Compounds for kinase modulation, and indications therefor201910,370,374Heterocyclic compounds and uses thereof201910,227,357Compounds and methods for kinase modulation, and indications therefor201910,160,747Compounds and methods for kinase modulation, and indications therefor20189,975,894Heterocyclic compounds and uses thereof20189,873,700Compounds for kinase modulation, and indications therefor20189,856,259'Heterocyclic compounds and uses thereof'20189,844,539Compounds and methods for kinase modulation, and indications therefor20179,814,714'Kinase modulation, and indications therefor'20179,771,363'Heterocyclic compounds and uses thereof'20179,718,847'Heterocyclic compounds and uses thereof'20179,624,213'Compounds and methods for kinase modulation, and indications therefor'20179,617,267'Compounds and methods for kinase modulation, and indications therefor'20179,469,640'Compounds and methods for kinase modulation, and indications therefor'20168,673,928'Compounds and methods for kinase modulation, and indications therefor'20148,268,858'Compounds and methods for kinase modulation, and indications therefor'20128,198,273'Compounds and methods for kinase modulation, and indications therefor'20128,153,641'Compounds and methods for kinase modulation, and indications therefor'20128,093,231'Sulfonylethyl phosphorodiamidates'20127,262,182'Sulfonylethyl phosphorodiamidates'20077,071,231'Naphthalene ureas as glucose uptake enhancers'20066,653,321'Naphthylsulfonic acids and related compounds as glucose uptake agonists'20036,458,998'Naphthalene ureas as glucose uptake enhancers'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2012Patents assigned to TELIK INC (5)· patent assignee history
2002–2021Based in Fremont, CA, US· patent location history
2012–2021Patents assigned to PLEXXIKON INC (23)· patent assignee history
2012–2017Patents assigned to SHI SONGYUAN (6)· patent assignee history
2012–2017Patents assigned to CHO HANNA (5)· patent assignee history
2012–2017Patents assigned to SPEVAK WAYNE (5)· patent assignee history
2012–2017Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PLEXXIKON INC232012–2021
SHI SONGYUANself62012–2017
CHO HANNA52012–2017
SPEVAK WAYNE52012–2017
TELIK INC52002–2012
Locations
LocationPatentsSpan
Fremont, California, US262002–2021
San Diego, California, US22012–2017